Skip to main content
Equibles
CERS logo

CERS · Cerus Corp

Track CERS — free

Use CERS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.59 +0.02 (+0.78%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$521.95M
Shares
201.52M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.59 Open$2.56 Day$2.54–2.60 52W close$1.18–3.28 Avg vol 30d2.5M Short int17.3M · 8.6% float · 5.1d Short vol75% Last earningsJul 30, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 8 wks
Latest filing: 10-Q
filed Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$249.22M
Trailing 12 months
Net income (TTM)
−$6.78M
Trailing 12 months
Revenue growth YoY
+9.5%
Year over year
Operating margin
-3.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-0.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.8%
Year over year · more shares
Price change (1Y)
+94.7%
Trailing year
Short interest
8.6%
Latest settlement · 5.1 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +9%
above
Price vs 50-day avg −8%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 67%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +10%
trailing
6-month return +44%
trailing
YTD return +26%
this year
Relative strength +29%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow Accumulating
+9% holders QoQ · +34 funds added
Insider flow Distributing
Net -$53.2K over 90 days · 100% sells
Short interest Rising
8.60% of float · ▲ +15.8% MoM · 5.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
186 holders — near 3-yr high, broad support
Squeeze score 63
elevated · 0–100
Fundamentals
Excellent
Revenue growth +31%
Y/Y
Gross margin 33%
expanding
EPS growth +27%
Y/Y
Free cash flow $1.1M
Balance sheet $24.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 79%
annualized · 1-yr
Max drawdown −38%
past year
ATR 5.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+9% Bullish
Price vs 50-day avg
−8% Bearish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
67% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow Accumulating
+9% holders QoQ · +34 funds added
Insider flow Distributing
Net -$53.2K over 90 days · 100% sells
Short interest Rising
8.60% of float · ▲ +15.8% MoM · 5.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
186 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $3 · 67% Range high $3
vs 200-day avg +9% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CERS
Cerus Corp
this stock
$521.95M +25.7% +30.7% — 8.6%
ABT
Abbott Laboratories
 $189.18B -13.5% +5.7% 30.4 1.2%
MDT
Medtronic plc
 $120.46B -2.0% +8.4% 23.2 1.1%
SYK
Stryker Corp
 $118.14B -13.8% +11.2% 31.9 1.8%
BSX
Boston Scientific Corp
 $69.27B -49.9% +12.5% 19.4 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
186
% held
74.7%
Net QoQ
-1.3M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
142
View
Short & Settlement
Short Interest Rising
Shares short
17.3M
Days to cover
5.1d
Change
+2.4M sh
View
Short Volume
Short vol %
75%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
1.1K
Value
$2.7K
As of
Aug 11, 2026
View
Off-Exchange
Off-exchange %
49.7%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$53.2K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$233.8M
Net income (FY)
$-15.6M
EPS diluted
$-0.08
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 30, 2026
This year
14
View
Proposed Sales
Value
$89.5K
Shares
30.0K
Filed
Aug 17, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 30, 2026
View
Investor Relations
Latest news
Cerus Corporation Announces Secon…
Published
Jul 30, 2026
View

Performance

5D 20D 120D MTD YTD
CERS -2.3% +10.2% +43.9% -1.9% +25.7%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -2.4% +10.6% +28.8% -2.3% +12.8%
Key facts CIK 1020214 CUSIP 157085101 13F (30d) 149 filings 147 filers Visit website Investor relations